IMPACT OF TP53 MUTATION ON OUTCOME OF MDS PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT (HSCT). GESMD STUDY

被引：0

作者：

Diez Campelo, M. ^{[1
]}

Caballero, J. C. ^{[1
]}

Sanchez Barba, M. ^{[2
]}

Del Rey, M. ^{[3
]}

Janusz, K. ^{[3
]}

Lumbreras, E. ^{[3
]}

Abaigar, M. ^{[3
]}

Robledo, C. ^{[3
]}

Jerez, A. ^{[4
]}

Calderon-Cabrera, C. ^{[5
]}

Such, E. ^{[6
]}

Cervera, J. ^{[6
]}

Sanz, G. ^{[6
]}

Valcarcel, D. ^{[7
]}

Hernandez-Rivas, J. M. ^{[1
]}

Del Canizo, C. ^{[1
]}

机构：

[1] Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain

[2] Univ Salamanca, Estadist, E-37008 Salamanca, Spain

[3] Hosp Univ Salamanca, Ctr Invest Canc USAL CSIC, Salamanca, Spain

[4] Hosp Univ Morales Meseguer, Serv Hematol & Oncol, Murcia, Spain

[5] Hosp Univ Virgen del Rocio, Serv Hematol, Seville, Spain

[6] Hosp Univ La Fe, Serv Hematol, Valencia, Spain

[7] Hosp Univ Vall dHebron, Serv Hematol, Barcelona, Spain

来源：

关键词：

D O I：

10.1016/S0145-2126(15)30207-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

206

引用

页码：S102 / S103

页数：2